preeclampsia. Gestational [pregnancy-induced] hypertension with significant proteinuria Excl.: superimposed pre-eclampsia (O11) O14.0 Moderate pre-eclampsia O14.1 Severe pre-eclampsia
Conditions
Interventions
Intervention 1: Intervention 1 :
Administration of Vitamin D3, 50000 IU ,pearl. Intervention 2: intervention 2: Administration of placebo.
Prevention
Treatment - Drugs
Intervention 1 :
Administration of Vitamin D3, 50000 IU ,pearl
intervention 2: Administration of placebo
Sponsors
Vice chancellor for research, Kurdistan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
15 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria : pregnancy , history of preeclampsia in a previous pregnancy , blood levels of vitamin D above 32 nanograms per milliliter Exclusion criteria : the risk of chronic hypertension before pregnancy , chronic kidney disease associated pulmonary and cardiovascular , immunological diseases such as lupus , the uncertainty of patient cooperation in the study , immigration or study leave.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Systolic and Diastolic blood pressure. Timepoint: In initiation of study, 2 week after intervention, per 2 week to termination of pregnancy. Method of measurement: Blood pressure is measured in the sitting position by using mercury barometer.;Proteinuria. Timepoint: If there is a blood pressure greater than or equal to 140/90 mm Hg. Method of measurement: laboratory kit. | — |
Secondary
| Measure | Time frame |
|---|---|
| Preeclampsia Recognition. Timepoint: After 28 weeks of pregnancy. Method of measurement: Measurement of blood pressure by using barometer, clinical symptoms and proteinuria detection by using laboratory kit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShole Shah Gheibi
Besat Hospital, Sannandaj
Outcome results
None listed